Pharmacodynamics:
Carbocisteine (S-carboxymethyl L-cysteine) has been shown in normal and bronchitic animal models to affect the nature and amount of mucus glycoprotein which is secreted by the respiratory tract. . Studies in humans have demonstrated that carbocisteine reduces goblet cell hyperplasia. Carbocisteine can therefore be demonstrated to have a role in the management of disorders characterised by abnormal mucus..

Pharmacokinetics:
Carbocisteine is rapidly absorbed from the GI tract.

Contraindications:
Mucothiol paediatric is contraindicated for use in children less than 2 years age.
Hypersensitivity to the active substance or to any of the excipients.
Use in Special Populations:

Pregnancy:
Although tests in mammalian species have revealed no teratogenic effects, Mucothiol is not recommended during the first trimester of pregnancy.

Use in lactation:
Effects not known.

Side effects:
Immune System Disorders
There have been reports of anaphylactic reactions and fixed drug eruption.
Skin and subcutaneous tissue disorders
There have been reports of skin rashes and allergic skin eruptions.
Gastrointestinal disorders
There have been rare reports of gastrointestinal bleeding occurring during treatment with Mucodyne.
Warnings/Precautions:
Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.

Dosage and Administration:
Children aged 2 to 5 years:
One 5ml measuring spoon 2 times per day
Children aged over 5 years:
One 5ml measuring spoon 3 times per day

Storage:
Do not store above 30⁰C. Store in a dry place. Protect from direct sunlight. Keep out of reach of children. Do not refrigerate.
Use within 30 days of first opening of the bottle.

About Product

16 March, 2015

UCL’S PRESENCE

UCL has spread its presence in most of the countries in this Region. Currently we do business with Malawi, Mozambique, Zambia, Burundi, Rwanda, Congo, DRC, Sierra –Leone, Somalia, Angola, Tanzania & Uganda

In The News

The latest feather on the cap is the site approval from the most stringent W.H.O, Geneva. Since 2005 we are growing at a very high rate of almost 25 % every year despite the fact that our first full year business activity as UCL was in 2006